-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Q2 Earnings Season Won’t Be as Ugly as Headlines Suggest
After stripping out the catastrophe that is the energy sector, estimated second-quarter earnings and sales growth isn't half bad.
Aetna-Humana Merger Is Bad News For ANTM, CI
Aetna (AET) and Humana (HUM) are getting married. And that may kill the Anthem (ANTM) - Cigna (CI) merger talks.
With Obamacare Secured, HCA Has Huge Potential
Now that Obamacare has passed yet another test at the Supreme Court, it looks like select healthcare stocks such as HCA have very bright futures.
Supreme Court Gives Healthcare Stocks a Booster Shot
The high court's ACA ruling bolsters the bull case for healthcare stocks, especially hospital companies such as HCA, CYH and THC.
BioMarin (BMRN) Stock Soars, Taking IBB With It
BioMarin (BMRN) stock is soaring on Thursday after promising Phase 2 trial data on a dwarfism drug, vosoritide. The IBB ETF is rallying, too.
How to Forecast Pharma Stocks (PFE, RAD, JNJ)
Pharma companies like PFE, JNJ and RAD are very tricky for fundamental analysts. But principles of relative-strength analysis should still be applied to confirm the fundamental factors.
Can Biotech Stocks Break Out, Or Will They Break Down?
Biotech stocks are a step up from lottery tickets: Fortunes made and lost on the clinical results and regulatory approval. Will they break down or break out?
Trade of the Day: Pfizer (PFE)
PFE is bouncing off support -- and, as a perennial powerhouse, we expect the stock to move back up toward its recent highs.
Did Alexion Jump the Shark With Its Synageva Bid? (ALXN, GEVA)
While ALXN seems to have overpaid for GEVA on the surface. However, investors can expect to see the benefits over the long-term.
Trade of the Day: Cigna (CI)
Health care stocks were the only group to mostly survive Monday's slump. Today’s recommendation is for a trade in that very sector.
Investing in Alzheimer’s Disease Drugs Just Became Complicated
Everything pharmaceutical companies thought they knew about Alzheimer's disease may (or may not) be wrong.
Trade of the Day: Rigel Pharmaceuticals (RIGL)
I'm still focusing on bullish trades given that stock market support levels have held.
